Comparative study of lipid nanoparticle-based mRNA vaccine bioprocess with machine learning and combinatorial artificial neural network-design of experiment approach

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Comparative study of lipid nanoparticle-based mRNA vaccine bioprocess with machine learning and combinatorial artificial neural network-design of experiment approach. / Maharjan, Ravi; Hada, Shavron; Eun Lee, Ji; Han, Hyo-Kyung; Hyun Kim, Ki; Jin Seo, Hye; Foged, Camilla; Hoon Jeong, Seong.

In: International Journal of Pharmaceutics, Vol. 640, 123012, 2023.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Maharjan, R, Hada, S, Eun Lee, J, Han, H-K, Hyun Kim, K, Jin Seo, H, Foged, C & Hoon Jeong, S 2023, 'Comparative study of lipid nanoparticle-based mRNA vaccine bioprocess with machine learning and combinatorial artificial neural network-design of experiment approach', International Journal of Pharmaceutics, vol. 640, 123012. https://doi.org/10.1016/j.ijpharm.2023.123012

APA

Maharjan, R., Hada, S., Eun Lee, J., Han, H-K., Hyun Kim, K., Jin Seo, H., Foged, C., & Hoon Jeong, S. (2023). Comparative study of lipid nanoparticle-based mRNA vaccine bioprocess with machine learning and combinatorial artificial neural network-design of experiment approach. International Journal of Pharmaceutics, 640, [123012]. https://doi.org/10.1016/j.ijpharm.2023.123012

Vancouver

Maharjan R, Hada S, Eun Lee J, Han H-K, Hyun Kim K, Jin Seo H et al. Comparative study of lipid nanoparticle-based mRNA vaccine bioprocess with machine learning and combinatorial artificial neural network-design of experiment approach. International Journal of Pharmaceutics. 2023;640. 123012. https://doi.org/10.1016/j.ijpharm.2023.123012

Author

Maharjan, Ravi ; Hada, Shavron ; Eun Lee, Ji ; Han, Hyo-Kyung ; Hyun Kim, Ki ; Jin Seo, Hye ; Foged, Camilla ; Hoon Jeong, Seong. / Comparative study of lipid nanoparticle-based mRNA vaccine bioprocess with machine learning and combinatorial artificial neural network-design of experiment approach. In: International Journal of Pharmaceutics. 2023 ; Vol. 640.

Bibtex

@article{0481158ddc3d47b5897d54c616590106,
title = "Comparative study of lipid nanoparticle-based mRNA vaccine bioprocess with machine learning and combinatorial artificial neural network-design of experiment approach",
abstract = "To develop a combinatorial artificial-neural-network design-of-experiment (ANN-DOE) model, the effect of ionizable lipid, an ionizable lipid-to-cholesterol ratio, N/P ratio, flow rate ratio (FRR), and total flow rate (TFR) on the outcome responses of mRNA-LNP vaccine were evaluated using a definitive screening design (DSD) and machine learning (ML) algorithms. Particle size (PS), PDI, zeta potential (ZP), and encapsulation efficiency (EE) of mRNA-LNP were optimized within a defined constraint (PS 40-100 nm, PDI≤0.30, ZP≥(±)0.30 mV, EE≥70%), fed to ML algorithms (XGBoost, bootstrap forest, support vector machines, k-nearest neighbors, generalized regression-Lasso, ANN) and prediction was compared to ANN-DOE model. Increased FRR decreased the PS and increased ZP, while increased TFR increased PDI and ZP. Similarly, DOTAP and DOTMA produced higher ZP and EE. Particularly, a cationic ionizable lipid with an N/P ratio ≥6 provided a higher EE. ANN showed better predictive ability (R2=0.7269-0.9946), while XGBoost demonstrated better RASE (0.2833-2.9817). The ANN-DOE model outperformed both optimized ML models by R2=1.21% and RASE=43.51% (PS prediction), R2=0.23% and RASE=3.47% (PDI prediction), R2=5.73% and RASE=27.95% (ZP prediction), and R2=0.87% and RASE=36.95% (EE prediction), respectively, which demonstrated that ANN-DOE model was superior in predicting the bioprocess compared to independent models.",
author = "Ravi Maharjan and Shavron Hada and {Eun Lee}, Ji and Hyo-Kyung Han and {Hyun Kim}, Ki and {Jin Seo}, Hye and Camilla Foged and {Hoon Jeong}, Seong",
note = "Copyright {\textcopyright} 2023. Published by Elsevier B.V.",
year = "2023",
doi = "10.1016/j.ijpharm.2023.123012",
language = "English",
volume = "640",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Comparative study of lipid nanoparticle-based mRNA vaccine bioprocess with machine learning and combinatorial artificial neural network-design of experiment approach

AU - Maharjan, Ravi

AU - Hada, Shavron

AU - Eun Lee, Ji

AU - Han, Hyo-Kyung

AU - Hyun Kim, Ki

AU - Jin Seo, Hye

AU - Foged, Camilla

AU - Hoon Jeong, Seong

N1 - Copyright © 2023. Published by Elsevier B.V.

PY - 2023

Y1 - 2023

N2 - To develop a combinatorial artificial-neural-network design-of-experiment (ANN-DOE) model, the effect of ionizable lipid, an ionizable lipid-to-cholesterol ratio, N/P ratio, flow rate ratio (FRR), and total flow rate (TFR) on the outcome responses of mRNA-LNP vaccine were evaluated using a definitive screening design (DSD) and machine learning (ML) algorithms. Particle size (PS), PDI, zeta potential (ZP), and encapsulation efficiency (EE) of mRNA-LNP were optimized within a defined constraint (PS 40-100 nm, PDI≤0.30, ZP≥(±)0.30 mV, EE≥70%), fed to ML algorithms (XGBoost, bootstrap forest, support vector machines, k-nearest neighbors, generalized regression-Lasso, ANN) and prediction was compared to ANN-DOE model. Increased FRR decreased the PS and increased ZP, while increased TFR increased PDI and ZP. Similarly, DOTAP and DOTMA produced higher ZP and EE. Particularly, a cationic ionizable lipid with an N/P ratio ≥6 provided a higher EE. ANN showed better predictive ability (R2=0.7269-0.9946), while XGBoost demonstrated better RASE (0.2833-2.9817). The ANN-DOE model outperformed both optimized ML models by R2=1.21% and RASE=43.51% (PS prediction), R2=0.23% and RASE=3.47% (PDI prediction), R2=5.73% and RASE=27.95% (ZP prediction), and R2=0.87% and RASE=36.95% (EE prediction), respectively, which demonstrated that ANN-DOE model was superior in predicting the bioprocess compared to independent models.

AB - To develop a combinatorial artificial-neural-network design-of-experiment (ANN-DOE) model, the effect of ionizable lipid, an ionizable lipid-to-cholesterol ratio, N/P ratio, flow rate ratio (FRR), and total flow rate (TFR) on the outcome responses of mRNA-LNP vaccine were evaluated using a definitive screening design (DSD) and machine learning (ML) algorithms. Particle size (PS), PDI, zeta potential (ZP), and encapsulation efficiency (EE) of mRNA-LNP were optimized within a defined constraint (PS 40-100 nm, PDI≤0.30, ZP≥(±)0.30 mV, EE≥70%), fed to ML algorithms (XGBoost, bootstrap forest, support vector machines, k-nearest neighbors, generalized regression-Lasso, ANN) and prediction was compared to ANN-DOE model. Increased FRR decreased the PS and increased ZP, while increased TFR increased PDI and ZP. Similarly, DOTAP and DOTMA produced higher ZP and EE. Particularly, a cationic ionizable lipid with an N/P ratio ≥6 provided a higher EE. ANN showed better predictive ability (R2=0.7269-0.9946), while XGBoost demonstrated better RASE (0.2833-2.9817). The ANN-DOE model outperformed both optimized ML models by R2=1.21% and RASE=43.51% (PS prediction), R2=0.23% and RASE=3.47% (PDI prediction), R2=5.73% and RASE=27.95% (ZP prediction), and R2=0.87% and RASE=36.95% (EE prediction), respectively, which demonstrated that ANN-DOE model was superior in predicting the bioprocess compared to independent models.

U2 - 10.1016/j.ijpharm.2023.123012

DO - 10.1016/j.ijpharm.2023.123012

M3 - Journal article

C2 - 37142140

VL - 640

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

M1 - 123012

ER -

ID: 345847704